Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to ₹22.20, the stock trades at a trailing P/E ratio of 60.4x. Average trailing P/E is 25x in the Pharmaceuticals industry in India. Total returns to shareholders of 81% over the past three years. 공시 • Mar 25
Panjon Limited to Report Q4, 2026 Results on May 30, 2026 Panjon Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on May 30, 2026 Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to ₹28.90, the stock trades at a trailing P/E ratio of 78.6x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 106% over the past three years. Reported Earnings • Feb 15
Third quarter 2026 earnings released Third quarter 2026 results: Revenue: ₹141.8m (up 27% from 3Q 2025). Net income: ₹2.16m (up 8.3% from 3Q 2025). Profit margin: 1.5% (down from 1.8% in 3Q 2025). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹24.27, the stock trades at a trailing P/E ratio of 67.8x. Average trailing P/E is 29x in the Pharmaceuticals industry in India. Total returns to shareholders of 46% over the past three years. New Risk • Jan 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (28% accrual ratio). Market cap is less than US$10m (₹350.3m market cap, or US$3.88m). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change). Valuation Update With 7 Day Price Move • Jan 13
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹20.41, the stock trades at a trailing P/E ratio of 57x. Average trailing P/E is 28x in the Pharmaceuticals industry in India. Total returns to shareholders of 19% over the past three years. 공시 • Dec 29
Panjon Limited to Report Q3, 2026 Results on Feb 14, 2026 Panjon Limited announced that they will report Q3, 2026 results on Feb 14, 2026 공시 • Sep 27
Panjon Limited to Report Q2, 2026 Results on Nov 14, 2025 Panjon Limited announced that they will report Q2, 2026 results on Nov 14, 2025 Reported Earnings • Aug 14
First quarter 2026 earnings released First quarter 2026 results: EPS: ₹0.006. Revenue: ₹64.5m (up 208% from 1Q 2025). Net income: ₹949.0k (up 174% from 1Q 2025). Profit margin: 1.5% (down from 1.7% in 1Q 2025). The decrease in margin was driven by higher expenses. 공시 • Aug 13
Panjon Limited, Annual General Meeting, Sep 30, 2025 Panjon Limited, Annual General Meeting, Sep 30, 2025, at 12:00 Indian Standard Time. Location: 01, panjon farm house, near hinkargiri jain tirth, airport-bijasan road indore, 452005(mp)., indore India 공시 • Jun 25
Panjon Limited to Report Q1, 2026 Results on Aug 14, 2025 Panjon Limited announced that they will report Q1, 2026 results on Aug 14, 2025 Reported Earnings • May 31
Full year 2025 earnings released: EPS: ₹0.032 (vs ₹0.098 in FY 2024) Full year 2025 results: EPS: ₹0.032. Revenue: ₹307.7m (up 145% from FY 2024). Net income: ₹5.27m (up 248% from FY 2024). Profit margin: 1.7% (up from 1.2% in FY 2024). The increase in margin was driven by higher revenue. 공시 • May 21
Panjon Limited to Report Q4, 2025 Results on May 29, 2025 Panjon Limited announced that they will report Q4, 2025 results on May 29, 2025 Reported Earnings • Feb 16
Third quarter 2025 earnings released Third quarter 2025 results: EPS: ₹0.011. Revenue: ₹112.4m (up 134% from 3Q 2024). Net income: ₹2.00m (up 379% from 3Q 2024). Profit margin: 1.8% (up from 0.9% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. 공시 • Dec 24
Panjon Limited to Report Q3, 2025 Results on Feb 14, 2025 Panjon Limited announced that they will report Q3, 2025 results on Feb 14, 2025 New Risk • Dec 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹591.8m market cap, or US$6.98m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). Shareholders have been diluted in the past year (27% increase in shares outstanding). Revenue is less than US$5m (₹155m revenue, or US$1.8m). New Risk • Nov 16
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.2% Last year net profit margin: 15% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹401.5m market cap, or US$4.76m). Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Shareholders have been diluted in the past year (27% increase in shares outstanding). Revenue is less than US$5m (₹155m revenue, or US$1.8m). Reported Earnings • Nov 16
Second quarter 2025 earnings released Second quarter 2025 results: EPS: ₹0.004. Revenue: ₹34.6m (up 167% from 2Q 2024). Net income: ₹666.0k (up 64% from 2Q 2024). Profit margin: 1.9% (down from 3.1% in 2Q 2024). The decrease in margin was driven by higher expenses. 공시 • Oct 01
Panjon Limited to Report Q2, 2025 Results on Nov 14, 2024 Panjon Limited announced that they will report Q2, 2025 results on Nov 14, 2024 Reported Earnings • Aug 15
First quarter 2025 earnings released First quarter 2025 results: EPS: ₹0.021. Revenue: ₹21.9m (up 77% from 1Q 2024). Net income: ₹346.0k (up 59% from 1Q 2024). Profit margin: 1.6% (down from 1.8% in 1Q 2024). The decrease in margin was driven by higher expenses. 공시 • Aug 14
Panjon Limited, Annual General Meeting, Sep 30, 2024 Panjon Limited, Annual General Meeting, Sep 30, 2024, at 13:00 Indian Standard Time. Location: 1, panjon farm house, near hinkargi, near hinkargi tirth, airport bijasan raod, indore - 452005, madhya pardesh, indore India 공시 • Jun 29
Panjon Limited to Report Q1, 2025 Results on Aug 14, 2024 Panjon Limited announced that they will report Q1, 2025 results on Aug 14, 2024 New Risk • Jun 01
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹293.6m market cap, or US$3.52m). Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Shareholders have been diluted in the past year (5.2% increase in shares outstanding). Revenue is less than US$5m (₹130m revenue, or US$1.6m). Reported Earnings • May 30
Full year 2024 earnings released: EPS: ₹0.098 (vs ₹0.52 in FY 2023) Full year 2024 results: EPS: ₹0.098 (down from ₹0.52 in FY 2023). Revenue: ₹130.1m (up 114% from FY 2023). Net income: ₹1.57m (down 81% from FY 2023). Profit margin: 1.2% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses. 공시 • May 19
Panjon Limited to Report Q4, 2024 Results on May 27, 2024 Panjon Limited announced that they will report Q4, 2024 results on May 27, 2024 Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹20.01, the stock trades at a trailing P/E ratio of 39.2x. Average trailing P/E is 32x in the Pharmaceuticals industry in India. Total returns to shareholders of 63% over the past year. Reported Earnings • Feb 15
Third quarter 2024 earnings released: EPS: ₹0.003 (vs ₹0.02 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.003. Revenue: ₹48.7m (up 255% from 3Q 2023). Net income: ₹417.0k (up 64% from 3Q 2023). Profit margin: 0.9% (down from 1.9% in 3Q 2023). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Feb 06
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹20.55, the stock trades at a trailing P/E ratio of 41.1x. Average trailing P/E is 34x in the Pharmaceuticals industry in India. Total returns to shareholders of 23% over the past year. 공시 • Dec 29
Panjon Limited to Report Q3, 2024 Results on Feb 14, 2024 Panjon Limited announced that they will report Q3, 2024 results on Feb 14, 2024 Reported Earnings • Nov 12
Second quarter 2024 earnings released: EPS: ₹0.003 (vs ₹0.003 in 2Q 2023) Second quarter 2024 results: EPS: ₹0.003 (in line with 2Q 2023). Revenue: ₹13.4m (down 33% from 2Q 2023). Net income: ₹406.0k (down 23% from 2Q 2023). Profit margin: 3.0% (up from 2.7% in 2Q 2023). The increase in margin was driven by lower expenses. 공시 • Aug 30
Panjon Limited Announces Resignation of Directors Panjon Limited announced that the company has received Resignation letter dated August 29, 2023 from Mr. Amit Mehta and Mr. Prakash Doshi from the post of Independent Director due to pre-occupation in other activities and inability to devote time to the business affairs of the Company. Mr. Amit Mehta is a Self Employed and has done his Bachelor of Engineering (BE) degree and has more than 15 years of experience in the business field. Mr. Prakash Doshi is a Self Employed and has done his Bachelor of Arts (BA) degree from Indore university. 공시 • Aug 13
Panjon Limited Announces Board Changes Panjon Limited announced that at its board meeting held on August 12, 2023, approved the resignation of Mr. Shubham Sharma - Company Secretary cum Compliance officer with effect from August 12, 2023; approved the appointment of Mrs. Arpita Vijayvargiya for the post of Company Secretary cum Compliance officer. Mr. Shubham Sharma is the Qualified Company Secretary & Associate Member of ICSI. He is Company Secretary & LLB. He is having a skills in SEBI Regulations, Companies Act, 2013 and other laws to ensure over all compliance of the Company. Mrs. Arpita Vijayvargiya is the Qualified Company Secretary & Associate Member of ICSI. She is having a skills in SEBI Regulations, Companies Act, 2013 and other laws to ensure over all compliance of the Company also having work exposure in Secretarial Work, Liasioning with ROC Filing of Statutory Forms on the MCA Portal, GST registration & Filings, Income tax filing, Tally etc. Reported Earnings • Aug 13
First quarter 2024 earnings released: EPS: ₹0.001 (vs ₹0.003 in 1Q 2023) First quarter 2024 results: EPS: ₹0.001 (down from ₹0.003 in 1Q 2023). Revenue: ₹13.2m (down 14% from 1Q 2023). Net income: ₹218.0k (down 51% from 1Q 2023). Profit margin: 1.7% (down from 2.9% in 1Q 2023). The decrease in margin was driven by lower revenue. 공시 • Jun 28
Panjon Limited to Report Fiscal Year 2023 Results on Aug 14, 2023 Panjon Limited announced that they will report fiscal year 2023 results on Aug 14, 2023 공시 • Jun 09
Panjon Limited Announces Resignation of Shubham Sharma as Company Secretary Panjon Limited announced that Mr. Shubham Sharma -Company Secretary cum Compliance officer of the Company has tendered his resignation on 7 June 2023. Buying Opportunity • Mar 21
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 32%. The fair value is estimated to be ₹16.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 46% over the last year. Meanwhile, the company became loss making. Reported Earnings • Feb 16
Third quarter 2023 earnings released: EPS: ₹0.02 (vs ₹1.65 loss in 3Q 2022) Third quarter 2023 results: EPS: ₹0.02 (up from ₹1.65 loss in 3Q 2022). Revenue: ₹14.2m (down 42% from 3Q 2022). Net income: ₹255.0k (up ₹21.5m from 3Q 2022). Profit margin: 1.8% (up from net loss in 3Q 2022). The move to profitability was driven by lower expenses. 공시 • Feb 15
Panjon Limited Announces Resignation of Sonamasati as Company Secretary and Compliance Officer Panjon Limited at its board of directors meeting held on February 14, 203, announced resignation of Ms. SonamAsati (Membership no: A67268) from the post of Company secretary and compliance officer, effective from 26 November, 2022. 공시 • Feb 12
Panjon Limited Appoints Shubham Sharma as Company Secretary and Compliance Officer Panjon Limited announced that at its Board Meeting of the Company held on February 11, 2023, approved the appointment of Mr. Shubham Sharma (Membership no: A70122) as the Company secretary and compliance officer with effect from 25 January, 2023. Mr. Shubham Sharma is the Qualified Company Secretary & Member of ICSI having Membership No. A70422. He is Company Secretary & LLB. He is having skills in SEBI Regulations, Companies Act, 2013 and other laws to ensure over all compliance of the Company. 공시 • Jan 23
Panjon Limited to Report Q3, 2023 Results on Feb 11, 2023 Panjon Limited announced that they will report Q3, 2023 results on Feb 11, 2023 Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Director Anju Kothari was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Nov 03
Panjon Limited to Report Q2, 2023 Results on Nov 11, 2022 Panjon Limited announced that they will report Q2, 2023 results on Nov 11, 2022 공시 • Aug 30
Panjon Limited, Annual General Meeting, Sep 30, 2022 Panjon Limited, Annual General Meeting, Sep 30, 2022, at 14:00 Indian Standard Time. Location: 01,Panjon Farm House ,Near Hinkargiri Jain Tirth,Airport-Bijasan Road Indore Madhya Pradesh India 공시 • Jun 29
Panjon Limited to Report Q1, 2023 Results on Aug 14, 2022 Panjon Limited announced that they will report Q1, 2023 results on Aug 14, 2022 공시 • Jun 05
Panjon Limited Announces Resignation of Khushbu Vohra as Company Secretary Panjon Limited announced that the resignation of Khushbu Vohra as company secretary of the company. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Director Anju Kothari was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Director Anju Kothari was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Director Anju Kothari was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 